REG - Alliance Pharma PLCAviva PLC - Major Interests in Shares <ALAPH.L><AV.L>
.
For best results when printing this announcement, please click on the link below:
http://pdf.reuters.com/Regnews/regnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20100729:nRSc1829Qa
RNS Number : 1829Q
Alliance Pharma PLC
29 July 2010
For immediate release 29 July 2010
Alliance Pharma plc
TR-1: Notification of major interests in shares
1. Identity of the issuer or the underlying issuer
Alliance Pharma plc
of existing shares to which voting rights are
attached:ii
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights
Yes
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already
issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the
Aviva plc & its subsidiaries
notification obligation:iii
4. Full name of shareholder(s)
Registered Holder: BNY Norwich Union Nominees Limited 1,138,491*
(if different from 3.):iv
Chase (GA Group) Nominees Limited
7,360,214* CUIM Nominee
Limited 2,770,404*
*denotes direct interest BNP Paribas - London
2,237,424 Chase
Nominees Limited 7,457,371 State Street Nominees
Limited
2,352,851
5. Date of the transaction and date on
28 July 2010
which the threshold is crossed or
reached:v
6. Date on which issuer notified:
29 July 2010
7. Threshold(s) that is/are crossed or
<10% to 10% Change at Combined Interest Level
reached: vi, vii
8. Notified details:
A: Voting rights attached to sharesviii, ix
Class/type of Situation previous Resulting situation after the triggering
transaction
shares to the triggering
if possible using transaction
the ISIN CODE
Number Number Number
Number of voting % of voting rights
of of of shares
rights
Shares Voting
Rights
Direct Direct xi Indirect xii
Direct Indirect
Ordinary Shares 21,516,755 21,516,755
23,316,755 11,269,109 12,047,646 4.85% 5.18%
GB0031030819
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial Expiration Exercise/
Number of voting % of voting
instrument date xiii Conversion Period xiv
rights that may be rights
acquired if the
instrument is
exercised/ converted.
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial Exercise price
Expiration date Exercise/ Number of voting rights instrument refers to % of voting rights
instrument
Conversion period
Nominal Delta
Total (A+B+C)
Number of voting rights Percentage of voting
rights
23,316,755 10.03%
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
The voting rights are managed and controlled by Aviva Investors Global Services Limited, with the following chain of
controlled undertakings:- Aviva Investors Global
Services Limited:· Aviva plc (Parent Company)· Aviva Group Holdings Limited (wholly owned subsidiary of Aviva
plc)· Aviva Investors Holdings Limited
(wholly owned subsidiary of Aviva Group Holdings Limited)· Aviva Investors Global Services Limited (wholly owned
subsidiary of Aviva Investors Holdings Limited)
Proxy Voting:
10. Name of the proxy holder:
See Section 4
11. Number of voting rights proxy holder will cease
to hold:
12. Date on which proxy holder will cease to hold
voting rights:
13. Additional information:
Figures are based on the total number of voting rights of
232,533,372.
14. Contact name:
Diane Thirkettle
15. Contact telephone number:
01603 687803
This information is provided by RNS
The company news service from the London Stock Exchange
